Monopar Therapeutics Inc. · NASDAQ:MNPR
Anderson Raymond sold 646 Monopar Therapeutics Inc. shares (Form 4)
Traded Aug 25, 2026 · Filed Aug 27, 2026
On Aug 25, 2026, Anderson Raymond (Director) sold 646 Monopar Therapeutics Inc. shares at US$110.07 for US$71,105 under a trading plan, leaving 25,523 shares. Filed Aug 27, 2026 (Form 4).
- Sold
- 646 shares
- Price
- US$110.07
- Value
- US$71,105
- Holding after
- 25,523 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Common Stock | Sale | 646 | US$110.07 | 25,523 | Direct |
Source
Related
- Monopar Therapeutics Inc.
- Anderson Raymond
- Monopar Therapeutics Inc. shareholders
- Form 4/A · Anderson Raymond · Aug 28, 2026
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026